RxDoctor Payments Data

Crystal Franklin

Optometrist · Pawleys Island, SCNPI 1518150374

Payments from drug & device makers

$1,700in general payments, 2019–2025

Across 27 payments — averaging $62.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$437
  • Optos, Inc.$287
  • Coopervision Inc.$275
  • AbbVie$262
  • Topcon Healthcare, Inc.$241
  • Bausch & Lomb Americas Inc.$106
  • plus $92 from 5 others

What the payments were for

  • Food & beverage$1,56792%
  • Entertainment$1328%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,700 in reported general payments places this provider in the 65th percentile of 653 optometrist providers in South Carolina.

See all optometrist providers in South Carolina

Medicare billing

Part B allowed, 2024
$85,100
Medicare patients
385
Services billed
7,421

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine62$69,365
Alphagan PBrimonidine Tartrate107$29,805
XiidraLifitegrast13$17,006
LumiganBimatoprost23$10,412
Brimonidine Tartrate73$8,969
Cyclosporine12$7,939
Tobramycin-DexamethasoneTobramycin/Dexamethasone146$5,892
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol20$2,000
Timolol Maleate141$941
Ofloxacin87$939
ErythromycinErythromycin Base61$693
Prednisolone Acetate21$691
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha31$374
Latanoprost74$342
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat29$251

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRestasis, Alphagan P, Lumigan$262$109,581192 claims
Bausch & Lomb Americas Inc.Xiidra$106$17,00613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 653 optometrist providers in South Carolina.

Other optometrist in Pawleys Island

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →